Cost analysis for CPT 81542 — Mrna gene expression analysis of 22 genes in prostate tumor tissue
Average Medicare Payment
$3788.63
2023 data
Total Payments (2023)
$71.7M
Services (2023)
18.9K
Price Change (2020–2023)
-1.3%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2020 | $3838.41 | $19.7M | 5.1K | — |
| 2021 | $3860.11 | $37.3M | 9.7K | +0.6% |
| 2022 | $3811.14 | $52.5M | 13.8K | -1.3% |
| 2023 | $3788.63 | $71.7M | 18.9K | -0.6% |
The most expensive state pays 1.0x more than the cheapest for this procedure. CA averages $3788.63 vs CA at $3788.63.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| CA | $3788.63 | $71.7M | 18.9K | 1 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Veracyte Labs Sd Corporation | Clinical Laboratory | CA | $71.7M | 18.9K | $3788.63 |
Based on the data, CPT 81542 shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Costs have decreased 1.3% since 2020. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.